Hyderabad: Kodudula Naveen Reddy, owner of Mr Tea and Mister Irani tea franchise chains, has been served a six-month banishment notice by the Rachakonda police commissioner for his alleged criminal ...

'Anaganaga Oka Raju' is continuing its good run at the box office. The film has now completed 10 days in theatres. On its tenth day, the film earned around Rs 1 crore in India net. With this the total ...

HYDERABAD: Congress candidate Naveen Yadav won the Jubilee Hills Assembly by-election, defeating rivals Sunita of BRS and L Deepak Reddy of BJP. Counting began on Friday amid tight security, with ...

DALLAS, TX (IANS) – Actor Naveen Polishetty, who is known for his work in Telugu cinema, and rose to prominence with the sketches of the comedy collective ‘AIB’, has been injured as he met with a bike ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

LOS ANGELES, CA – Amazon’s latest series, “The Pradeeps of Pittsburgh,” is a comedy that is anchored in the immigrant ethos and highlights both the challenges and joys of families navigating a new ...

Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

Today, January 23, is an important milestone in the legal and constitutional history of India. Twenty-two years ago, on this day, the Supreme Court of India, in the case Union of India versus Naveen ...

https://www.thehindubusinessline.com/companies/dr-reddys-laboratories-q3-results-net-profit-slips-15-to-1189-cr/article70533294.ece Copy Dr Reddy’s Laboratories ...

Dr Reddy's India business saw robust double-digit growth, with revenue increasing 19% y-o-y to ₹1,603 crore. Hyderabad-based Dr Reddy’s Laboratories beat street estimates in the third quarter, ...

Shares of Dr Reddy’s Laboratories surged over 4 percent in early trade on Thursday after the pharmaceutical company delivered a better-than-expected set of Q3 FY26 results, prompting brokerages to ...